Nordea Investment Management Ab Adaptive Biotechnologies Corp Transaction History

Nordea Investment Management Ab

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 02, 2024	SELL	$2.88 - $4.8 $26,593 - $44,323	-9,234 Reduced 1.06%	859,214 $2.76 Million
Q4 2023 Jan 10, 2024	SELL	$3.46 - $5.33 $88,655 - $136,570	-25,623 Reduced 2.87%	868,448 $4.26 Million
Q3 2023 Nov 13, 2023	BUY	$5.07 - $8.44 $2.59 Million - $4.31 Million	510,292 Added 132.97%	894,071 $4.87 Million
Q2 2023 Jul 07, 2023	SELL	$6.19 - $8.78 $849,453 - $1.2 Million	-137,230 Reduced 26.34%	383,779 $2.58 Million
Q1 2023 Apr 19, 2023	BUY	$7.8 - $10.11 $4.06 Million - $5.27 Million	521,009 New	521,009 $4.6 Million

202

146M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $849M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Nordea Investment Management Ab, based on Form 13F filings with the SEC.

Stay updated on Nordea Investment Management Ab with notifications on news.